연구동향 분석
박사

Role of inactive Rhomboid protease 2 (iRhom2) in intestinal ischemia-reperfusion-mediated acute lung injury

김지현 2018년

논문상세정보
    • 저자 김지현
    • 형태사항 26 cm
    • 일반주기 지도교수: 김주성
    • 학위논문사항 서울대학교 대학원, 2018. 8, 의학과, 학위논문(박사)-
    • DDC 610
    • 발행지 서울
    • 언어 eng
    • 출판년 2018
    • 발행사항 서울대학교 대학원
    유사주제 논문( 4,049)
인용/피인용
' Role of inactive Rhomboid protease 2 (iRhom2) in intestinal ischemia-reperfusion-mediated acute lung injury' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의료과학 약
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
3,949 0

0.0%

' Role of inactive Rhomboid protease 2 (iRhom2) in intestinal ischemia-reperfusion-mediated acute lung injury' 의 참고문헌

  • Wilcox, M. G., Howard, T. J., Plaskon, L. A., Unthank, J. L. & Madura, J. A. Current theories of pathogenesis and treatment of nonocclusive mesenteric ischemia. Dig Dis Sci 40, 709-716 (1995).
  • Thomas, S., Karnik, S. & Balasubramanian, K. Surgical manipulation of the small intestine and its effect on the lung. J Surg Res 106, 145-156 (2002).
  • Sun, Z. et al. Effects of inhibition of PAF, ICAM-1 and PECAM-1 on gut barrier failure caused by intestinal ischemia and reperfusion. Scand J Gastroenterol 36, 55-65 (2001).
  • Su, A. I. et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A 101, 6062-6067 (2004).
  • Souza, D. et al. Effects of the PAF receptor antagonist UK74505 on local and remote reperfusion injuries following ischaemia of the superior mesenteric artery in the rat. Br J Pharmacol 131, 1800-1808 (2000).
  • Souza, D. G., Cassali, G. D., Poole, S. & Teixeira, M. M. Effects of inhibition of PDE4 and TNF‐α on local and remote injuries following ischaemia and reperfusion injury. Br J Pharmacol 134, 985-994 (2001).
  • Souza, D. G. et al. The essential role of the intestinal microbiota in facilitating acute inflammatory responses. J Immunol 173, 4137-4146 (2004).
  • Souza, D. G. et al. Increased mortality and inflammation in tumor necrosis factor-stimulated gene-14 transgenic mice after ischemia and reperfusion injury. The Am J Pathol 160, 1755-1765 (2002).
  • Souza, D. G. et al. Effects of PKF242-484 and PKF241-466, novel dual inhibitors of TNF-alpha converting enzyme and matrix metalloproteinases, in a model of intestinal reperfusion injury in mice. Eur J Pharmacol 571, 72- 80 (2007).
  • Sorkine, P. et al. Soluble tumor necrosis factor receptors reduce bowel ischemia-induced lung permeability and neutrophil sequestration. Crit Care Med 23, 1377-1381 (1995).
  • Soares, A. L. et al. Tumor necrosis factor is not associated with intestinal ischemia/reperfusion-induced lung inflammation. Shock 34, 306-313 (2010).
  • Shimizu, M. et al. Effects of TNF-α-converting enzyme inhibition on acute lung injury induced by endotoxin in the rat. Shock 32, 535-540 (2009).
  • Seo, J. Y. et al. Nimbolide Inhibits Nuclear Factor‐КB Pathway in Intestinal Epithelial Cells and Macrophages and Alleviates Experimental Colitis in Mice. Phytother Res 30, 1605-1614 (2016).
  • Peschon, J. J. et al. An essential role for ectodomain shedding in mammalian development. Science 282, 1281-1284 (1998).
  • Perl, M. et al. Fas-induced pulmonary apoptosis and inflammation during indirect acute lung injury. Am J Respir Crit Care Med 176, 591-601 (2007).
  • Oudijk, E. D. et al. Systemic inflammation in COPD visualised by gene profiling in peripheral blood neutrophils. Thorax 60, 538-544 (2005).
  • Ortiz, L. A. et al. Upregulation of the p75 but not the p55 TNF-α receptor mRNA after silica and bleomycin exposure and protection from lung injury in double receptor knockout mice. Am J Respir Cell Mol Biol 20, 825-833 (1999).
  • Moss, M. L. et al. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385, 733 (1997).
  • Moore, F. A. The role of the gastrointestinal tract in postinjury multiple organ failure. Am J Surg 178, 449-453 (1999).
  • Mitoma, H. et al. Mechanisms for cytotoxic effects of anti–tumor necrosis factor agents on transmembrane tumor necrosis factor α–expressing cells: comparison among infliximab, etanercept, and adalimumab. Arthritis Rheum 58, 1248-1257 (2008).
  • Messer, M. P. et al. Silencing of fas, fas-associated via death domain, or caspase 3 differentially affects lung inflammation, apoptosis, and development of trauma-induced septic acute lung injury. Shock 39, 19-27 (2013).
  • McIlwain, D. R. et al. iRhom2 regulation of TACE controls TNF-mediated protection against Listeria and responses to LPS. Science 335, 229-232 (2012).
  • Marcos-Ramiro, B., Garc a-Weber, D. & Mill n, J. TNF-induced endothelial barrier disruption: beyond actin and Rho. Thromb Haemost 112, 1088-1102 (2014).
  • Lu, H. Y., Zhang, J., Wang, Q. X., Tang, W. & Zhang, L. J. Activation of the endoplasmic reticulum stress pathway involving CHOP in the lungs of rats with hyperoxia‑induced bronchopulmonary dysplasia. Mol Med Rep 12, 4494-4500 (2015).
  • Lemberg, M. K. & Freeman, M. Functional and evolutionary implications of enhanced genomic analysis of rhomboid intramembrane proteases. Genome Res 17, 1634-1646 (2007).
  • Laster, S., Wood, J. & Gooding, L. Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. J Immunol 141, 2629-2634 (1988).
  • Kozar, R. A. et al. Superior mesenteric artery occlusion models shockinduced gut ischemia-reperfusion. J Surg Res 116, 145-150 (2004).
  • Koh, S.-J. et al. Fluoxetine inhibits NF-κB signaling in intestinal epithelial cells and ameliorates experimental colitis and colitis-associated colon cancer in mice. Am J Physiol Gastrointest Liver Physiol 301, G9-G19 (2011).
  • Klempnauer, J., Grothues, F., Bektas, H. & Pichlmayr, R. Long-term results after surgery for acute mesenteric ischemia. Surgery 121, 239-243 (1997).
  • Kitamura, Y. et al. Fas/FasL-dependent apoptosis of alveolar cells after lipopolysaccharide-induced lung injury in mice. Am J Respir Crit Care Med 163, 762-769 (2001).
  • Khadaroo, R. G. et al. I-FABP as biomarker for the early diagnosis of acute mesenteric ischemia and resultant lung injury. PLoS One 9, e115242 (2014).
  • Kaymakcalan, Z. et al. Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor. Clin Immunol 131, 308-316 (2009).
  • Kassahun, W. T., Schulz, T., Richter, O. & Hauss, J. Unchanged high mortality rates from acute occlusive intestinal ischemia: six year review. Langenbecks Arch Surg 393, 163-171 (2008).
  • K ksoy, C., Kuzu, M., Kuzu, I., Erg n, H. & G rhan, I. Role of tumour necrosis factor in lung injury caused by intestinal ischaemia–reperfusion. Br J Surg 88, 464-468 (2001).
  • Jabuulonska, E., Kiluk, M., Markiewicz, W. & Jabuulonski, J. Priming effects of GM-CSF, IFN-γ and TNF-α on human neutrophil inflammatory cytokine production. Melanoma Res 12, 123-128 (2002).
  • Issuree, P. D. A. et al. iRHOM2 is a critical pathogenic mediator of inflammatory arthritis. J Clin Invest 123, 928-932 (2013).
  • He, X. et al. Anti-human tissue factor antibody ameliorated intestinal ischemia reperfusion-induced acute lung injury in human tissue factor knockin mice. PLoS One 3, e1527 (2008).
  • Harkin, D., D'sa, A. B., McCallion, K. & Hoper, M. Circulating neutrophil priming and systemic inflammation in limb ischaemia-reperfusion injury. Int Angiol 20, 78 (2001).
  • Hamacher, J. r. et al. Tumor necrosis factor-α and angiostatin are mediators of endothelial cytotoxicity in bronchoalveolar lavages of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 166, 651-656 (2002).
  • Gilmont, R. R. et al. TNF-α potentiates oxidant and reperfusion-induced endothelial cell injury. J Surg Res 61, 175-182 (1996).
  • Georgopoulos, S., Plows, D. & Kollias, G. Transmembrane TNF is sufficient to induce localized tissue toxicity and chronic inflammatory arthritis in transgenic mice. J inflamm 46, 86-97 (1996).
  • Gearing, A. et al. Processing of tumour necrosis factor-α precursor by metalloproteinases. Nature 370, 555-557 (1994).
  • Ferrante, A., Nandoskar, M., Walz, A., Goh, D. H. & Kowanko, I. C. Effects of tumour necrosis factor alpha and interleukin-1 alpha and beta on human neutrophil migration, respiratory burst and degranulation. Int Arch Allergy Appl Immunol 86, 82-91 (1988).
  • Eissner, G., Kolch, W. & Scheurich, P. Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system. Cytokine Growth Factor Rev 15, 353-366 (2004).
  • Chun, J., Lee, C., Hwang, S. W., Im, J. P. & Kim, J. S. Ursolic acid inhibits nuclear factor-κB signaling in intestinal epithelial cells and macrophages, and attenuates experimental colitis in mice. Life Sci 110, 23-34 (2014).
  • Chen, L.-W. et al. The two faces of IKK and NF-κB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat Med 9, 575-581 (2003).
  • Chalaris, A. et al. Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice. J Exp Med, jem. 20092366 (2010).
  • Cavriani, G. et al. Lymphatic system as a path underlying the spread of lung and gut injury after intestinal ischemia/reperfusion in rats. Shock 23, 330-336 (2005).
  • Black, R. A. et al. A metalloproteinase disintegrin that releases tumour necrosis factor-R from cells. Nature 385, 729-733 (1997).
  • Arora, T. et al. Differences in binding and effector functions between classes of TNF antagonists. Cytokine 45, 124-131 (2009).
  • Alexopoulou, L., Pasparakis, M. & Kollias, G. A murine transmembrane tumor necrosis factor (TNF) transgene induces arthritis by cooperative p55/p75 TNF receptor signaling. Eur J Immunol 27, 2588-2592 (1997).
  • Adrain, C., Zettl, M., Christova, Y., Taylor, N. & Freeman, M. Tumor necrosis factor signaling requires iRhom2 to promote trafficking and activation of TACE. Science 335, 225-228 (2012).